2.04
+0.03(+1.49%)
Currency In USD
| Previous Close | 2.01 |
| Open | 2.16 |
| Day High | 2.16 |
| Day Low | 1.94 |
| 52-Week High | 21.96 |
| 52-Week Low | 1.56 |
| Volume | 243,634 |
| Average Volume | 835,413 |
| Market Cap | 3.67M |
| PE | -0.2 |
| EPS | -10.08 |
| Moving Average 50 Days | 4.04 |
| Moving Average 200 Days | 5.22 |
| Change | 0.03 |
If you invested $1000 in Organovo Holdings, Inc. (ONVO) 10 years ago, it would be worth $20.4 as of April 28, 2025 at a share price of $2.04. Whereas If you bought $1000 worth of Organovo Holdings, Inc. (ONVO) shares 5 years ago, it would be worth $244.02 as of April 28, 2025 at a share price of $2.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
VivoSim to Carry Forward Organovo 3D Bioprinting
GlobeNewswire Inc.
Apr 23, 2025 12:05 PM GMT
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc. A name change of the Company to VivoSim Labs, I
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
GlobeNewswire Inc.
Apr 02, 2025 12:05 PM GMT
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today r
Organovo Provides Business Update
GlobeNewswire Inc.
Mar 27, 2025 12:05 PM GMT
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today pro
Data not available